Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jazz, Hikma resolve patent litigation surrounding Xyrem

Executive Summary

Resolving ongoing patent litigation between Jazz Pharmaceuticals PLC and Hikma Pharmaceuticals PLC surrounding Jazz's Xyrem (sodium oxybate) oral solution, Jazz granted Hikma the right to sell an authorized sodium oxybate generic.
Deal Industry
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register